COSMO Pharmaceuticals SA Share Price Swiss Exchange
Equities
LU1202320294
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Sales 2024 * | 264M 286M 256M 23.83B | Sales 2025 * | 242M 262M 235M 21.86B | Capitalization | 1.19B 1.29B 1.16B 108B |
---|---|---|---|---|---|
Net income 2024 * | 130M 141M 126M 11.75B | Net income 2025 * | 66M 71.48M 64.05M 5.96B | EV / Sales 2024 * | 4.11 x |
Net cash position 2024 * | 112M 121M 108M 10.1B | Net cash position 2025 * | 220M 238M 213M 19.87B | EV / Sales 2025 * | 4.03 x |
P/E ratio 2024 * |
9.49
x | P/E ratio 2025 * |
12.9
x | Employees | - |
Yield 2024 * |
2.87% | Yield 2025 * |
1.58% | Free-Float | 44.36% |
Latest transcript on COSMO Pharmaceuticals SA
Managers | Title | Age | Since |
---|---|---|---|
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 01/16/01 |
Chairman | 61 | 01/06/01 | |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 69 | 01/97/01 | |
Director/Board Member | 69 | 01/12/01 | |
Chairman | 61 | 01/06/01 |
1st Jan change | Capi. | |
---|---|---|
+56.89% | 809B | |
+39.52% | 624B | |
-6.86% | 351B | |
+7.53% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.80% | 166B | |
-2.71% | 157B |